We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More
Read MoreHide Full Article
Plenty to chew on in the after-market round of Q2 earnings releases this Wednesday, with Facebook , which has been priced to near-perfection, delivering on that very high bar. We also see results for Amgen (AMGN - Free Report) , Whole Foods and Groupon (GRPN - Free Report) hitting the tape this afternoon.
Facebook just posted a monster Q2 earnings report, trouncing analyst estimates on both top and bottom lines. Earnings of 76 cents per share (accounting for stock-based compensation and other BNRI) beat the Zacks consensus of 62 cents. Quarterly sales reached $6.44 billion, far ahead of the $6.01 billion expected and up 59% year over year. Daily active users (DAU), monthly active users (MAU) and average revenue per user were all better than expected. Mobile revenue was as well, and went up 81% year over year. Shares shot up 6.6% immediately after the news. For more on FB's earnings, click here.
Groupon shares shot up 24% on a strong Q2 in both sales and loss per share. The bottom line figure of -0.06 cents (accounting for stock-based compensation and other BNRI) improved on the Zacks consensus of -0.07 per share. Revenues of $756 million easily beat the $712 million expected. The company also revised guidance upward for fiscal 2016. For more on GRPN's earnings, click here.
Biotech major Amgen topped expectations on both Q2 sales and earnings. The maker of Enbrel and Neulasta beat earnings expectations of $2.74 by 10 cents. Revenues of $5.69 billion beat the Zacks consensus estimate of $5.60 billion. The company also raised guidance for fiscal 2016 from $11.20 per share to $11.40 per share. Shares have slipped about a quarter post-report, but AMGN stock was up roughly 18% over the past month.
Whole Foods met top and bottom line Q3 estimates exactly: 37 cents per share on $3.7 billion in revenues. Gross margins were slightly better than expected, but a same-store sales read of -2.6% was worse than expected. The company expects same-store sales to go positive next quarter, though guided a penny lower for Q4 earnings. For more on WFM's earnings, click here.
Want more insight on Q2 earnings? Check out Zacks Director of Research Sheraz Mian's latest Earnings Trends right here.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More
Plenty to chew on in the after-market round of Q2 earnings releases this Wednesday, with Facebook , which has been priced to near-perfection, delivering on that very high bar. We also see results for Amgen (AMGN - Free Report) , Whole Foods and Groupon (GRPN - Free Report) hitting the tape this afternoon.
Facebook just posted a monster Q2 earnings report, trouncing analyst estimates on both top and bottom lines. Earnings of 76 cents per share (accounting for stock-based compensation and other BNRI) beat the Zacks consensus of 62 cents. Quarterly sales reached $6.44 billion, far ahead of the $6.01 billion expected and up 59% year over year. Daily active users (DAU), monthly active users (MAU) and average revenue per user were all better than expected. Mobile revenue was as well, and went up 81% year over year. Shares shot up 6.6% immediately after the news. For more on FB's earnings, click here.
Groupon shares shot up 24% on a strong Q2 in both sales and loss per share. The bottom line figure of -0.06 cents (accounting for stock-based compensation and other BNRI) improved on the Zacks consensus of -0.07 per share. Revenues of $756 million easily beat the $712 million expected. The company also revised guidance upward for fiscal 2016. For more on GRPN's earnings, click here.
Biotech major Amgen topped expectations on both Q2 sales and earnings. The maker of Enbrel and Neulasta beat earnings expectations of $2.74 by 10 cents. Revenues of $5.69 billion beat the Zacks consensus estimate of $5.60 billion. The company also raised guidance for fiscal 2016 from $11.20 per share to $11.40 per share. Shares have slipped about a quarter post-report, but AMGN stock was up roughly 18% over the past month.
Whole Foods met top and bottom line Q3 estimates exactly: 37 cents per share on $3.7 billion in revenues. Gross margins were slightly better than expected, but a same-store sales read of -2.6% was worse than expected. The company expects same-store sales to go positive next quarter, though guided a penny lower for Q4 earnings. For more on WFM's earnings, click here.
Want more insight on Q2 earnings? Check out Zacks Director of Research Sheraz Mian's latest Earnings Trends right here.